Publications

Journal Article Epublish 78 citations
Electronic publication date
July 13, 2011

View on Pubmed.gov 21747814 | View on doi.org 10.3389/fmicb.2...

Molecular Investigations of PenA-mediated β-lactam Resistance in Burkholderia pseudomallei.

Search for publications in this journal Front Microbiol

Abstract

Burkholderia pseudomallei is the etiological agent of melioidosis. Because of the bacterium's intrinsic resistance and propensity to establish latent infections, melioidosis therapy is complicated and prolonged. Newer generation β-lactams, specifically ceftazidime, are used for acute phase therapy, but resistance to this cephalosporin has been observed. The chromosomally encoded penA gene encodes a putative twin arginine translocase (TAT)-secreted β-lactamase, and penA mutations have been implicated in ceftazidime resistance in clinical isolates. However, the role of PenA in resistance has not yet been systematically studied in isogenetic B. pseudomallei mutant backgrounds. We investigated the effects of penA deletion, point mutations, and up-regulation, as well as tat operon deletion and PenA TAT-signal sequence mutations. These experiments were made possible by employing a B. pseudomallei strain that is excluded from Select Agent regulations. Deletion of penA significantly (>4-fold) reduced the susceptibility to six of the nine β-lactams tested and ≥16-fold for ampicillin, amoxicillin, and carbenicillin. Overexpression of penA by single-copy, chromosomal expression of the gene under control of the inducible P(tac) promoter, increased resistance levels for all β-lactams tested 2- to 10-fold. Recreation of the C69Y and P167S PenA amino acid substitutions previously observed in resistant clinical isolates increased resistance to ceftazidime by ≥85- and 5- to 8-fold, respectively. Similarly, a S72F substitution resulted in a 4-fold increase in resistance to amoxicillin and clavulanic acid. Susceptibility assays with PenA TAT-signal sequence and ΔtatABC mutants, as well as Western blot analysis, confirmed that PenA is a TAT secreted enzyme and not periplasmic but associated with the spheroplastic cell fraction. Lastly, we determined that two LysR-family regulators encoded by genes adjacent to penA do not play a role in transcriptional regulation of penA expression.

References

Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20440-5

Gene. 1994 Oct 11;148(1):81-6

J Bacteriol. 2005 Nov;187(22):7667-79

J Clin Microbiol. 2009 May;47(5):1556-8

Cited by 78 citations (total)

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia.

Electronic publication date June 30, 2012

Search for publications in this journal PLoS One

Derek S Sarovich [...] David M Wagner et al.

Burkholderia pseudomallei is a gram-negative bacterium that causes the serious human disease, melioidosis. There is no vaccine against melioidosis and...

Journal Article Research Support, N.I.H., Extramural

Evolution of Burkholderia pseudomallei in recurrent melioidosis.

Electronic publication date September 15, 2012

Search for publications in this journal PLoS One

Hillary S Hayden [...] Michael A Jacobs et al.

Burkholderia pseudomallei, the etiologic agent of human melioidosis, is capable of causing severe acute infection with overwhelming septicemia leading to...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties